Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell‐free DNA by next‐generation sequencing

Next‐generation sequencing of cell‐free DNA (cfDNA) has been shown to be a useful noninvasive test for detecting mutations in solid tumors.

[1]  Michael C. Heinold,et al.  A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing , 2015, Nature Communications.

[2]  A. Hauschild,et al.  Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials , 2015, Clinical Cancer Research.

[3]  Toru Kumagai,et al.  Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA. , 2015, Clinical chemistry.

[4]  Nicholas J. Wang,et al.  Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease , 2015, PloS one.

[5]  C. Frühbeis,et al.  Release of bulk cell free DNA during physical exercise occurs independent of extracellular vesicles , 2015, European Journal of Applied Physiology.

[6]  Yuan Qi,et al.  Clinical actionability enhanced through deep targeted sequencing of solid tumors. , 2015, Clinical chemistry.

[7]  V. Wong,et al.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.

[8]  K. Shaw,et al.  Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. , 2015, Cancer letters.

[9]  Daniel Bernstein,et al.  Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection , 2014, Science Translational Medicine.

[10]  M. Choti,et al.  Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.

[11]  Ash A. Alizadeh,et al.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.

[12]  Guochun Wang,et al.  Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus. , 2014, Internal medicine.

[13]  Terence P. Speed,et al.  Comparing somatic mutation-callers: beyond Venn diagrams , 2013, BMC Bioinformatics.

[14]  N. Rosenfeld,et al.  Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA , 2013, Nature.

[15]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[16]  S. Quake,et al.  Universal noninvasive detection of solid organ transplant rejection , 2011, Proceedings of the National Academy of Sciences.

[17]  K. Yoon,et al.  Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. , 2009, The Journal of molecular diagnostics : JMD.

[18]  C. Vrettou,et al.  Cell-free DNA levels in acute myocardial infarction patients during hospitalization , 2009, Acta cardiologica.

[19]  H. C. Fan,et al.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.

[20]  R. Catarino,et al.  Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. , 2008, DNA and cell biology.

[21]  V. Vlassov,et al.  Circulating DNA in the Blood of Gastric Cancer Patients , 2008, Annals of the New York Academy of Sciences.

[22]  A. Burd,et al.  Plasma cell-free DNA as an indicator of severity of injury in burn patients , 2006, Clinical chemistry and laboratory medicine.

[23]  Walter Weder,et al.  Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Dueñas-González,et al.  Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients , 2003, International journal of cancer.

[25]  K. Tsao,et al.  Elevated cell-free serum DNA detected in patients with myocardial infarction. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[26]  F. O. Fackelmayer,et al.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.

[27]  Y. Lo,et al.  Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. , 1999, Clinical chemistry.

[28]  Y. Lo,et al.  Rapid clearance of fetal DNA from maternal plasma. , 1999, American journal of human genetics.

[29]  C. Steinman,et al.  Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. , 1990, The Journal of clinical investigation.